Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro

Wenhui Yan, Meng Zhang, Ye Yu, Xinyao Yi, Tingli Guo, Hao Hu, Qiang Sun, Mingxia Chen, Huangui Xiong, Lina Chen

Research output: Contribution to journalArticle

Abstract

The voltage-gated potassium (Kv) channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have shown beneficial effects on some neurological disorders. But their involvements in diabetes-associated cognitive dysfunction are still unknown. The present study aims to investigate whether the blockade of Kv channels by TEA and 4-AP alleviate cognitive decline in diabetes. In vivo, the effects of TEA and 4-AP (5 mg/kg body weight per day, 1 mg/kg body weight per day intraperitoneal injected for 4 weeks, respectively) were investigated in streptozotocin-induced C57BL/6 diabetic mice. In vitro study, we investigated the effects of TEA and 4-AP on the high glucose (HG) -stimulated primary cortical neurons. The results showed that TEA and 4-AP ameliorated the cognitive decline of diabetic mice in the Morris water maze test, improved the ultrastructure of pancreatic β cells, hippocampal neurons and synapses, decreased oxidative stress, modulated apoptosis-related proteins, and activated phosphatidylinositol 3-kinase (PI3K)/ Protein kinase-B (PKB or Akt) signaling pathway. In the HG-stimulated primary cultured cortical neurons, TEA and 4-AP increased the cell viability, decreased oxidative stress; prevented apoptosis and activated PI3K/Akt signaling pathway. Additionally, the PI3K inhibitor LY294002 partially abolished the effects of TEA and 4-AP. These findings indicate that the blockade of Kv channels by TEA and 4-AP ameliorates the diabetes-associated cognitive dysfunction via PI3K/Akt pathway, suggesting that targeting Kv channels could be a promising strategy for the treatments of cognitive impairments in diabetes.

Original languageEnglish (US)
Article number112988
JournalExperimental Neurology
Volume320
DOIs
StatePublished - Oct 1 2019

Fingerprint

Voltage-Gated Potassium Channels
4-Aminopyridine
Tetraethylammonium
Phosphatidylinositol 3-Kinase
Neurons
Oxidative Stress
Body Weight
Potassium Channel Blockers
Apoptosis
Glucose
Proto-Oncogene Proteins c-akt
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
In Vitro Techniques
Cognitive Dysfunction
Streptozocin
Nervous System Diseases
Synapses
Cell Survival
Water

Keywords

  • 4-Aminopyridine
  • Apoptosis
  • Diabetes-associated cognitive dysfunction
  • Hippocampus
  • Oxidative stress
  • Tetraethylammonium

ASJC Scopus subject areas

  • Neurology
  • Developmental Neuroscience

Cite this

Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro. / Yan, Wenhui; Zhang, Meng; Yu, Ye; Yi, Xinyao; Guo, Tingli; Hu, Hao; Sun, Qiang; Chen, Mingxia; Xiong, Huangui; Chen, Lina.

In: Experimental Neurology, Vol. 320, 112988, 01.10.2019.

Research output: Contribution to journalArticle

Yan, Wenhui ; Zhang, Meng ; Yu, Ye ; Yi, Xinyao ; Guo, Tingli ; Hu, Hao ; Sun, Qiang ; Chen, Mingxia ; Xiong, Huangui ; Chen, Lina. / Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro. In: Experimental Neurology. 2019 ; Vol. 320.
@article{a1fa838e698d4de7b548d719a7347fea,
title = "Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro",
abstract = "The voltage-gated potassium (Kv) channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have shown beneficial effects on some neurological disorders. But their involvements in diabetes-associated cognitive dysfunction are still unknown. The present study aims to investigate whether the blockade of Kv channels by TEA and 4-AP alleviate cognitive decline in diabetes. In vivo, the effects of TEA and 4-AP (5 mg/kg body weight per day, 1 mg/kg body weight per day intraperitoneal injected for 4 weeks, respectively) were investigated in streptozotocin-induced C57BL/6 diabetic mice. In vitro study, we investigated the effects of TEA and 4-AP on the high glucose (HG) -stimulated primary cortical neurons. The results showed that TEA and 4-AP ameliorated the cognitive decline of diabetic mice in the Morris water maze test, improved the ultrastructure of pancreatic β cells, hippocampal neurons and synapses, decreased oxidative stress, modulated apoptosis-related proteins, and activated phosphatidylinositol 3-kinase (PI3K)/ Protein kinase-B (PKB or Akt) signaling pathway. In the HG-stimulated primary cultured cortical neurons, TEA and 4-AP increased the cell viability, decreased oxidative stress; prevented apoptosis and activated PI3K/Akt signaling pathway. Additionally, the PI3K inhibitor LY294002 partially abolished the effects of TEA and 4-AP. These findings indicate that the blockade of Kv channels by TEA and 4-AP ameliorates the diabetes-associated cognitive dysfunction via PI3K/Akt pathway, suggesting that targeting Kv channels could be a promising strategy for the treatments of cognitive impairments in diabetes.",
keywords = "4-Aminopyridine, Apoptosis, Diabetes-associated cognitive dysfunction, Hippocampus, Oxidative stress, Tetraethylammonium",
author = "Wenhui Yan and Meng Zhang and Ye Yu and Xinyao Yi and Tingli Guo and Hao Hu and Qiang Sun and Mingxia Chen and Huangui Xiong and Lina Chen",
year = "2019",
month = "10",
day = "1",
doi = "10.1016/j.expneurol.2019.112988",
language = "English (US)",
volume = "320",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Blockade of voltage-gated potassium channels ameliorates diabetes-associated cognitive dysfunction in vivo and in vitro

AU - Yan, Wenhui

AU - Zhang, Meng

AU - Yu, Ye

AU - Yi, Xinyao

AU - Guo, Tingli

AU - Hu, Hao

AU - Sun, Qiang

AU - Chen, Mingxia

AU - Xiong, Huangui

AU - Chen, Lina

PY - 2019/10/1

Y1 - 2019/10/1

N2 - The voltage-gated potassium (Kv) channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have shown beneficial effects on some neurological disorders. But their involvements in diabetes-associated cognitive dysfunction are still unknown. The present study aims to investigate whether the blockade of Kv channels by TEA and 4-AP alleviate cognitive decline in diabetes. In vivo, the effects of TEA and 4-AP (5 mg/kg body weight per day, 1 mg/kg body weight per day intraperitoneal injected for 4 weeks, respectively) were investigated in streptozotocin-induced C57BL/6 diabetic mice. In vitro study, we investigated the effects of TEA and 4-AP on the high glucose (HG) -stimulated primary cortical neurons. The results showed that TEA and 4-AP ameliorated the cognitive decline of diabetic mice in the Morris water maze test, improved the ultrastructure of pancreatic β cells, hippocampal neurons and synapses, decreased oxidative stress, modulated apoptosis-related proteins, and activated phosphatidylinositol 3-kinase (PI3K)/ Protein kinase-B (PKB or Akt) signaling pathway. In the HG-stimulated primary cultured cortical neurons, TEA and 4-AP increased the cell viability, decreased oxidative stress; prevented apoptosis and activated PI3K/Akt signaling pathway. Additionally, the PI3K inhibitor LY294002 partially abolished the effects of TEA and 4-AP. These findings indicate that the blockade of Kv channels by TEA and 4-AP ameliorates the diabetes-associated cognitive dysfunction via PI3K/Akt pathway, suggesting that targeting Kv channels could be a promising strategy for the treatments of cognitive impairments in diabetes.

AB - The voltage-gated potassium (Kv) channel blockers tetraethylammonium (TEA) and 4-aminopyridine (4-AP) have shown beneficial effects on some neurological disorders. But their involvements in diabetes-associated cognitive dysfunction are still unknown. The present study aims to investigate whether the blockade of Kv channels by TEA and 4-AP alleviate cognitive decline in diabetes. In vivo, the effects of TEA and 4-AP (5 mg/kg body weight per day, 1 mg/kg body weight per day intraperitoneal injected for 4 weeks, respectively) were investigated in streptozotocin-induced C57BL/6 diabetic mice. In vitro study, we investigated the effects of TEA and 4-AP on the high glucose (HG) -stimulated primary cortical neurons. The results showed that TEA and 4-AP ameliorated the cognitive decline of diabetic mice in the Morris water maze test, improved the ultrastructure of pancreatic β cells, hippocampal neurons and synapses, decreased oxidative stress, modulated apoptosis-related proteins, and activated phosphatidylinositol 3-kinase (PI3K)/ Protein kinase-B (PKB or Akt) signaling pathway. In the HG-stimulated primary cultured cortical neurons, TEA and 4-AP increased the cell viability, decreased oxidative stress; prevented apoptosis and activated PI3K/Akt signaling pathway. Additionally, the PI3K inhibitor LY294002 partially abolished the effects of TEA and 4-AP. These findings indicate that the blockade of Kv channels by TEA and 4-AP ameliorates the diabetes-associated cognitive dysfunction via PI3K/Akt pathway, suggesting that targeting Kv channels could be a promising strategy for the treatments of cognitive impairments in diabetes.

KW - 4-Aminopyridine

KW - Apoptosis

KW - Diabetes-associated cognitive dysfunction

KW - Hippocampus

KW - Oxidative stress

KW - Tetraethylammonium

UR - http://www.scopus.com/inward/record.url?scp=85067870921&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067870921&partnerID=8YFLogxK

U2 - 10.1016/j.expneurol.2019.112988

DO - 10.1016/j.expneurol.2019.112988

M3 - Article

VL - 320

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

M1 - 112988

ER -